The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that ...

The Tulane team has developed a handful of other assays for TB detection, including mass spec test for paucibacillary TB that is being commercialized by Nanopin Tech, and a non-sputum CRISPR-based lab ...

Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

With approximately 37 million people living with HIV worldwide and an estimated 2 million new infections reported each year, the need to derive novel strategies aimed at eradicating HIV-1 infection ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human ...